As of June this year, based on Qiagen's most recent financial report, the company's trailing twelve months EPS is $1.87. During 2025, QGEN reported a per-share earnings of $1.96, which shows a rise compared to the EPS of $0.38 recorded in 2024. Qiagen's EPS for the quarterly period ending on Mar 31, 2026 came in at $0.33.
The yearly earnings per share during 2025 was $1.96, a rise of 415.8% compared to $0.38 recorded in 2024. Over the quarter ending Mar 31, 2026, the earnings per share came in at $0.33, reflecting a 21.4% decline compared to the same quarter a year earlier. As of March 2026, the TTM EPS is $1.87. During 2024, the annual earnings per share was $0.38, representing a decrease of 74.7% compared to 2023.
Qiagen has recorded a decline in earnings per share of 21.4% in the past 12 months (YoY, quarterly). During the past three years, QGEN registered an average yearly EPS growth of 1.8%. Qiagen had an average annual EPS growth of 3.9% in the last five years. Over the last decade, QGEN had an average annual earnings per share growth of 12.9%.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| QGEN Qiagen NV | 19.83 | 415.8% | 1.8% | 3.9% |
| TMO Thermo Fisher Scientific Inc | 25.49 | 7.2% | 0% | 2% |
| BDX Becton Dickinson & Co | 36.34 | -0.9% | -0.6% | 16.2% |
| GE General Electric Co | 43.57 | 35.8% | 447.4% | 12.1% |
| TECH BIO-TECHNE Corp | 79.31 | -56.1% | -35.2% | -20.7% |
All data is based on quarterly TTM periods, unless otherwise specified.